Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption | Zendy

Jun Chen | Zendy; Zeng | Zendy; Gao | Zendy; Hu | Zendy; Song | Zendy; Xia | Zendy; Liu | Zendy; Gu | Zendy; Zhiqing Pang | Zendy; Chen Chen | Zendy; Fang Fang Fang Fang | Zendy

Open Access

Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption

Author(s) -

Jun Chen,

Zeng,

Gao,

Hu,

Song,

Xia,

Liu,

Gu,

Zhiqing Pang,

Chen Chen,

Fang Fang Fang Fang

Publication year - 2012

Publication title -

international journal of nanomedicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.245

H-Index - 128

eISSN - 1178-2013

pISSN - 1176-9114

DOI - 10.2147/ijn.s32599

Subject(s) - in vivo , drug delivery , absorption (acoustics) , nanoparticle , drug , materials science , nanotechnology , drug carrier , pharmacology , medicine , microbiology and biotechnology , biology , composite material

Lipid-based liquid crystalline nanoparticles (LCNPs) have attracted growing interest as novel drug-delivery systems for improving the bioavailability of both hydrophilic and hydrophobic drugs. However, their cellular interaction and in vivo behavior have not been fully developed and characterized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research